On Friday, November 12, 2021, Sentara Hospital System in Virginia submitted a motion to dismiss the complaint filed against it earlier in the week by Dr. Paul Marik—co-chief medical officer of the FLCCC, tenured professor, and the Director of the Intensive Care Unit at Sentara Norfolk General Hospital. Dr. Marik filed suit seeking a temporary injunction to lift the ban Sentara Healthcare System had placed on a range of highly effective COVID-19 treatments used by Dr. Marik to save critically ill COVID-19 patients. These components, including IV vitamin C, dutasteride, fluvoxamine, finasteride, and ivermectin, had previously been successfully used—with the exception of ivermectin, the use of which Sentara never permitted
0 subscriptions will be displayed on your profile (edit)
Skip for now
For your security, we need to re-authenticate you.
Click the link we sent to , or click here to sign in.